Consistent with this finding, treatment with RO4929097 (RO), a γ-secretase inhibitor, inhibited the ability of STC1 to promote the stemness properties of HCC cells and decreased the expression of stemness genes in HCC cells (Additional file 3: Fig. S3B–F). The gene discussed is STC1; the disease is hepatocellular carcinoma.